Hepatitis C Virus Infection, Response to Therapy of

Infectious Diseases
2
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

M&
Merck & Co.RAHWAY, NJ
1 program
1
Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]Phase 41 trial
Active Trials
NCT03381859Withdrawn0Est. Jun 2020
Akros Pharma
Akros PharmaNJ - Princeton
1 program
1
JTK-853Phase 11 trial
Active Trials
NCT01473056Completed29Est. Sep 2011
AbbVie
AbbVieNORTH CHICAGO, IL
1 program
Test and treat plus peer mentorsN/A1 trial
Active Trials
NCT04677153Completed124Est. Sep 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Merck & Co.Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
Akros PharmaJTK-853
AbbVieTest and treat plus peer mentors

Clinical Trials (3)

Total enrollment: 153 patients across 3 trials

NCT03381859Merck & Co.Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]

Clinical Trial to eLiminate HCV-infection in Treatment-naïve, Renally Impaired EgyptiAn Patients on Renal Dialysis, With Chronic Hepatitis C Genotype 4

Start: Dec 2019Est. completion: Jun 20200
Phase 4Withdrawn

Study to Assess Safety,Tolerability,Pharmacokinetics & Antiviral Activity of JTK-853 in Hepatitis C Virus Genotype 1 Infected Subjects

Start: Aug 2010Est. completion: Sep 201129 patients
Phase 1Completed
NCT04677153AbbVieTest and treat plus peer mentors

Rapid HCV Treatment Access for Persons Who Use Drugs

Start: Aug 2021Est. completion: Sep 2024124 patients
N/ACompleted

Related Jobs in Infectious Diseases

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space